- Conditions
- Bacterial Vaginosis
- Interventions
- Metronidazole oral tablets 500mg, 1% SPL7013 Gel, Placebo gel
- Drug
- Lead sponsor
- Starpharma Pty Ltd
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 637 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • San Diego, California • Metairie, Louisiana + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–30
of 30
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Skin Manifestations
- Interventions
- metronidazole 1% gel, azelaic acid 15% gel
- Drug
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 77 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Colorado Springs, Colorado
- Conditions
- Bacterial Vaginosis
- Interventions
- GDC-229, Metronidazole Vaginal Gel 0.75%, Placebo
- Drug
- Lead sponsor
- Balmoral Medical company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 871 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Raleigh, North Carolina
- Conditions
- Bacterial Vaginosis
- Interventions
- Metronidazole oral tablets 500mg, 1% SPL7013 Gel, Placebo gel
- Drug
- Lead sponsor
- Starpharma Pty Ltd
- Industry
- Eligibility
- 16 Years to 45 Years · Female only
- Enrollment
- 586 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 37
- States / cities
- Birmingham, Alabama • Montgomery, Alabama • Little Rock, Arkansas + 32 more
- Conditions
- Bacterial Vaginosis
- Interventions
- Vaginal acidifying gel (RepHresh), Metronidazole control
- Drug
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Healthy
- Interventions
- Metronidazole
- Drug
- Lead sponsor
- Teva Pharmaceuticals USA
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 38 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2001 – 2002
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania